The price of this share is at 13,88$, Stoke Therapeutics Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Barry S. Ticho (Chief Medical Officer), Edward M. Kaye (Chief Executive Officer & Director), Gene Liau (Chief Scientific Officer), Huw M. Nash (Chief Operating & Business Officer), Stephen J. Tulipano (Chief Financial Officer) and its address is 45 WIGGINS AVENUE, BEDFORD, Massachusetts, 1730, United States.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 13,96$ moving between 13,73$ and 14,18$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The last value we have registered for the opening is desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
